Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management - Curetalks

Hear Talk Audio


Multiple Myeloma Stem Cells and Drug Resistance in Myeloma Management

Multiple myeloma is a heterogenous plasma cell disorder that contains a small fraction of clonogenic stem cells, just like many other cancers. Although the exact nature and biological properties of these cells remain elusive, multiple myeloma stem cells (MMSCs) have pronounced drug resistance and are believed to be the root cause of failure of many myeloma management therapies. We are talking to Dr William Matsui of LiveStrong Cancer Institutes to learn about the latest research on multiple myeloma stem cells and their role in novel drug development to treat multiple myeloma.

Panelists

Talk Recorded on Sep 30, 2019, 11:00 am EST </> Embed Find Multiple Myeloma Trials
<iframe src="https://www.curetalks.com/event-embed/79" id="frame" frameborder="0" scrolling="no" style="width: 100%; overflow: hidden; min-height: 500px;" ></iframe>

Submit a question for the panelists or leave a comment below.

Your email address will not be published. Required fields are marked *